PBTS yields 181.82% · PFE yields 6.20%● Live data
📍 PBTS pulled ahead of the other in Year 1
Combined, PBTS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PBTS + PFE for your $10,000?
Powerbridge Technologies Co., Ltd. provides software application and technology solutions and services primarily in China. It offers Powerbridge System Solutions that include Trade Enterprise and Trade Compliance, as well as Import & Export Loan and Insurance Processing for customers to streamline their trade operations, trade logistics, and regulatory compliance. The company also provides Powerbridge Software-as-a-Service solutions, which comprise Logistics Service Cloud and Trade Zone Operations Cloud, as well as Inward Processed Manufacturing Cloud, Cross-Border eCommerce Cloud, and Import & Export Loan; and Powerbridge Blockchain-as-a-Service solutions that include Compliance Blockchain and Supply Chain Blockchain Services. It serves international trade businesses and manufacturers, government agencies and authorities, and logistics service and other providers. The company sells its solutions and services through its direct sales organization, indirect channel partners, and strategic government partners. Powerbridge Technologies Co., Ltd. was founded in 1997 and is headquartered in Zhuhai, China.
Full PBTS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.